Contrast-enhanced mammography (CEM) and dedicated breast computed tomography (dBCT) are innovative techniques for evaluating breast tumour vascularity, providing valuable insights into tumour perfusion and enhancing breast cancer diagnosis accuracy [1]. CEM consists of a combination of low-energy (comparable to standard digital mammography [2]) and high-energy mammography images used to generate recombined images showing areas of contrast enhancement in a fashion comparable to breast MRI[3]. dBC…